华纳药厂
(688799)
| 流通市值：26.91亿 | | | 总市值：44.68亿 |
| 流通股本：5648.80万 | | | 总股本：9380.00万 |
| 报告期 | 2024-03-31 | 2023-12-31 | 2023-09-30 | 2023-06-30 |
| 公司类型 | 通用 | 通用 | 通用 | 通用 |
| 流动资产: | | | | |
| 货币资金 | 461,506,280.89 | 379,645,130.14 | 154,750,453.52 | 122,089,252.56 |
| 应收票据及应收账款 | 190,460,939.64 | 165,668,121.63 | 143,743,981.56 | 155,573,126.84 |
| 其中：应收票据 | 11,635,613.7 | 9,513,748.69 | 9,323,708.5 | 9,724,965.88 |
| 应收账款 | 178,825,325.94 | 156,154,372.94 | 134,420,273.06 | 145,848,160.96 |
| 应收款项融资 | 25,024,068.77 | 17,876,745.17 | 20,439,855.41 | 22,772,478.16 |
| 预付款项 | 12,108,874.67 | 15,030,836.71 | 9,948,992.04 | 2,455,047.65 |
| 其他应收款合计 | 2,381,159.52 | 2,136,203.93 | 2,424,976.75 | 2,304,912.01 |
| 存货 | 368,477,153.49 | 362,668,425.75 | 328,827,131.7 | 345,454,526.95 |
| 其他流动资产 | 351,716,672.46 | 391,721,973.16 | 365,618,179.08 | 376,097,001.41 |
| 流动资产平衡项目 | 0 | 0 | 0 | 0 |
| 流动资产合计 | 1,411,675,149.44 | 1,349,747,436.49 | 1,325,753,570.06 | 1,306,746,345.58 |
| 非流动资产: | | | | |
| 长期股权投资 | 54,982,127.38 | 47,145,534.49 | 37,510,276.33 | 34,379,542.12 |
| 投资性房地产 | 5,873,342.33 | 5,915,491.49 | 5,957,640.65 | 5,999,789.81 |
| 固定资产 | 554,614,902.02 | 569,152,819.04 | 582,406,921.19 | 595,209,756.38 |
| 在建工程 | 63,204,951.45 | 27,623,590.52 | 2,767,390.63 | 3,594,717.98 |
| 无形资产 | 75,555,972.99 | 76,623,786.69 | 77,722,825.34 | 78,832,605.78 |
| 商誉 | 32,381,982.12 | 32,381,982.12 | 32,381,982.12 | 32,381,982.12 |
| 长期待摊费用 | 5,214,698.99 | 5,323,610.55 | 2,991,553.28 | 2,654,799.73 |
| 递延所得税资产 | 19,380,515.65 | 18,734,209.95 | 13,881,385.67 | 16,673,015.45 |
| 其他非流动资产 | 43,515,606.95 | 44,294,434.45 | 40,326,663 | 20,297,800 |
| 非流动资产平衡项目 | 0 | 0 | 0 | 0 |
| 非流动资产合计 | 854,724,099.88 | 827,195,459.3 | 795,946,638.21 | 790,024,009.37 |
| 资产平衡项目 | 0 | 0 | 0 | 0 |
| 资产总计 | 2,266,399,249.32 | 2,176,942,895.79 | 2,121,700,208.27 | 2,096,770,354.95 |
| 流动负债: | | | | |
| 应付票据及应付账款 | 102,622,265.53 | 89,499,035.18 | 61,461,977.19 | 101,849,536.73 |
| 其中：应付票据 | - | - | - | 5,137,500 |
| 应付账款 | 102,622,265.53 | 89,499,035.18 | 61,461,977.19 | 96,712,036.73 |
| 预收款项 | 5,046,272.78 | 4,014,020.62 | 5,403,948.33 | 4,638,490.69 |
| 合同负债 | 70,770,153.97 | 76,112,961.74 | 56,080,583.87 | 62,470,890.18 |
| 应付职工薪酬 | 15,050,337.33 | 19,217,156.98 | 14,775,615.5 | 14,522,400.22 |
| 应交税费 | 20,673,494.73 | 17,873,539.31 | 17,330,912.11 | 4,690,288.76 |
| 其他应付款合计 | 118,803,785.31 | 118,161,616.73 | 94,261,158.37 | 75,836,784.44 |
| 一年内到期的非流动负债 | 36,187.52 | 13,685.1 | - | - |
| 其他流动负债 | 11,887,591.41 | 11,484,990 | 11,202,687.2 | 12,044,311.31 |
| 流动负债平衡项目 | 0 | 0 | 0 | 0 |
| 流动负债合计 | 344,890,088.58 | 336,377,005.66 | 260,516,882.57 | 276,052,702.33 |
| 非流动负债: | | | | |
| 长期借款 | 46,945,036 | 17,106,380 | - | - |
| 预计负债 | 5,282,000 | 5,282,000 | 5,282,000 | 5,282,000 |
| 递延收益 | 48,410,301.54 | 49,938,952.14 | 50,439,645.74 | 51,243,000.35 |
| 递延所得税负债 | - | - | 2,157,264.71 | 2,296,287.86 |
| 非流动负债平衡项目 | 0 | 0 | 0 | 0 |
| 非流动负债合计 | 100,637,337.54 | 72,327,332.14 | 57,878,910.45 | 58,821,288.21 |
| 负债平衡项目 | 0 | 0 | 0 | 0 |
| 负债合计 | 445,527,426.12 | 408,704,337.8 | 318,395,793.02 | 334,873,990.54 |
| 所有者权益(或股东权益): | | | | |
| 实收资本(或股本) | 93,800,000 | 93,800,000 | 93,800,000 | 93,800,000 |
| 资本公积 | 850,338,381.88 | 850,338,381.88 | 850,338,381.88 | 850,338,381.88 |
| 盈余公积 | 46,900,000 | 46,900,000 | 46,900,000 | 46,900,000 |
| 未分配利润 | 792,524,325.3 | 732,471,267.73 | 763,845,480.67 | 717,784,658.6 |
| 归属于母公司股东权益平衡项目 | 0 | 0 | 0 | 0 |
| 归属于母公司股东权益合计 | 1,783,562,707.18 | 1,723,509,649.61 | 1,754,883,862.55 | 1,708,823,040.48 |
| 少数股东权益 | 37,309,116.02 | 44,728,908.38 | 48,420,552.7 | 53,073,323.93 |
| 股东权益平衡项目 | 0 | 0 | 0 | 0 |
| 股东权益合计 | 1,820,871,823.2 | 1,768,238,557.99 | 1,803,304,415.25 | 1,761,896,364.41 |
| 负债和股东权益合计 | 2,266,399,249.32 | 2,176,942,895.79 | 2,121,700,208.27 | 2,096,770,354.95 |
| 公告日期 | 2024-04-20 | 2024-04-20 | 2023-10-30 | 2023-08-28 |
| 审计意见(境内) | | 标准无保留意见 | | |